Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:26 AM
Ignite Modification Date:
2025-12-25 @ 2:26 AM
NCT ID:
NCT02764034
Eligibility Criteria:
Inclusion Criteria:
Demographic:
* Women in child bearing period aging from 20 to 38 years.
* Only women up to 38 years will be included, to remove advanced age as a confounding factor that could affect the study results.
* BMI: \> 20 and \< 35 " BMI more 35 is excluded to remove any confounding factor related to increased BMI form the study"
* Human endometrial sample will be obtained from infertile women with the following conditions:
* Recurrent IUI, IVF or ICSI Failure without any clear cause.
* Women with unexplained infertility after exclusion of all other causes of infertility and exclusion of male factor.
Exclusion Criteria:
* Women with endometrial cancer or precancerous lesions.
* Women with any malignancy of the genital tract as vulval, vaginal, cervical, ovarian and other malignancies.
* Women undergoing dilatation and curettage due to the following conditions will be excluded:
* Any pregnancy related pathology (eg, incomplete abortion, missed abortion, septic abortion, induced pregnancy termination, treatment and evaluation of gestational trophoblastic disease).
* Dilatation and curettage for dysfunctional uterine bleeding; irregular bleeding or menorrhagia
* Hormonal treatment or any medication that may affect the endometrium, including any patient received hormonal therapy in the 3 months preceding the study.
* Before endometrial ablation for treatment of endometrial hyperplasia or perimenopausal bleeding.
* Tissues with proved precancerous or neoplastic changes in the endometrial sample will be discarded and eliminated before initiation of the study.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
38 Years
Study:
NCT02764034
Study Brief:
Protocol Section:
NCT02764034